The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-(Benzo[c][1,2,5]thiadiazol-5-yl)-5-(6-methylpyridin-2-yl)-1H-pyrazol-1-yl)-N-(2-fluorophenyl)acetamide ID: ALA4546065
PubChem CID: 155553271
Max Phase: Preclinical
Molecular Formula: C23H17FN6OS
Molecular Weight: 444.50
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cccc(-c2c(-c3ccc4nsnc4c3)cnn2CC(=O)Nc2ccccc2F)n1
Standard InChI: InChI=1S/C23H17FN6OS/c1-14-5-4-8-20(26-14)23-16(15-9-10-19-21(11-15)29-32-28-19)12-25-30(23)13-22(31)27-18-7-3-2-6-17(18)24/h2-12H,13H2,1H3,(H,27,31)
Standard InChI Key: YDPQHZIVRHOJDK-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 36 0 0 0 0 0 0 0 0999 V2000
10.5151 -5.0427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9122 -4.7497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4011 -3.0980 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
11.0294 -7.4619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3900 -3.9339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5761 -3.5894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9065 -5.5932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3000 -5.2970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0728 -6.4007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8946 -2.4286 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8837 -3.7710 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8575 -6.6550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1305 -4.2036 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.4761 -6.1017 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.6739 -3.5230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7191 -4.9175 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.8238 -3.9295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1066 -2.6903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6806 -2.6939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3882 -2.2812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1094 -3.5208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1258 -5.6272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9512 -5.6297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3616 -6.3458 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3662 -4.9163 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.1869 -6.3484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5937 -7.0676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4183 -7.0706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8340 -6.3566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4192 -5.6381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5960 -5.6387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1766 -7.7798 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
15 5 1 0
10 3 1 0
15 19 1 0
2 16 1 0
2 8 1 0
9 12 1 0
17 2 2 0
12 14 2 0
16 13 1 0
8 1 2 0
12 4 1 0
13 6 2 0
8 14 1 0
6 17 1 0
7 9 2 0
19 10 2 0
20 19 1 0
11 15 2 0
3 11 1 0
18 20 2 0
1 7 1 0
5 21 2 0
21 17 1 0
21 18 1 0
16 22 1 0
22 23 1 0
23 24 1 0
23 25 2 0
24 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 26 1 0
27 32 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 444.50Molecular Weight (Monoisotopic): 444.1169AlogP: 4.70#Rotatable Bonds: 5Polar Surface Area: 85.59Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.41CX Basic pKa: 4.28CX LogP: 4.11CX LogD: 4.11Aromatic Rings: 5Heavy Atoms: 32QED Weighted: 0.42Np Likeness Score: -2.19
References 1. Zhu WJ, Cui BW, Wang HM, Nan JX, Piao HR, Lian LH, Jin CH.. (2019) Design, synthesis, and antifibrosis evaluation of 4-(benzo-[c][1,2,5]thiadiazol-5-yl)-3(5)-(6-methyl- pyridin-2-yl)pyrazole and 3(5)-(6-methylpyridin- 2-yl)-4-(thieno-[3,2,-c]pyridin-2-yl)pyrazole derivatives., 180 [PMID:31299584 ] [10.1016/j.ejmech.2019.07.013 ]